Global Drug of Abuse Testing Market Report 2017-2027
Employment Testing, Random Testing, Reasonable Testing, Post-Accident Testing, Saliva, Breath, Urine, Blood, Hair, Sweat, Schools and Educational Institutes, Hospitals and Healthcare Units, Government and Private Departments and Others
The global drug of abuse testing market was valued at $4.4bn in 2016 and is projected to grow at a CAGR of 4.9% in the first half of the forecast period. The market is dominated by the Employment Testing submarket which held 39.3% share of that market in 2016.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 165 page report you will receive 78 tables and 71 figures – all unavailable elsewhere.
The 165-page report provides clear detailed insight into the global drug of abuse testing market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Drug of Abuse Testing Market forecasts from 2017-2027
• Revenue forecast for drug of abuse testing market by Type: • Employment Testing • Random Testing • Reasonable Testing • Post-Accident Testing • Other
Each submarket is further divided by region: North America, Latin America, Europe, APEJ, Japan and MEA
• Revenue forecast for drug of abuse testing market by Sample Type: • Saliva • Breath • Urine • Blood • Hair • Sweat
Each submarket is further divided by region: North America, Latin America, Europe, APEJ, Japan and MEA
• Revenue forecast for drug of abuse testing market by Application: • Schools and Educational Institutes • Hospitals and Healthcare Units • Government and Private Departments • Others
Each submarket is further divided by region: North America, Latin America, Europe, APEJ, Japan and MEA
• This report provides individual revenue forecasts to 2027 for these regional and national markets: • North America: the US and Canada • Latin America: Mexico, Brazil, Argentina • Europe: Germany, France, UK, Italy, Spain, Rest of Europe • APEJ: China, India, Australia, Rest of APEJ • MEA: GCC Countries, South Africa, Rest of MEA • Japan
Each regional market is further divided by type, sample type and application.
• This report discusses the leading companies in the global drug of abuse testing market: • Abbott • Danaher • Roche • Siemens • Biomerieux, Inc. • Bio-Rad Laboratories • Express Diagnostics International • Quest Diagnostics Incorporated • Thermo Fisher Scientific • Agilent Technologies, Inc.
• This report discusses the drivers, restraints as well as porter’s five forces analysis of the global drug of abuse testing market
Visiongain’s study is intended for anyone requiring commercial analyses for the global drug of abuse testing market. You find data, trends and predictions.
Buy our report today Global Drug of Abuse Testing Market Report 2017-2027: Employment Testing, Random Testing, Reasonable Testing, Post-Accident Testing, Saliva, Breath, Urine, Blood, Hair, Sweat, Schools and Educational Institutes, Hospitals and Healthcare Units, Government and Private Departments and Others.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Global Drug of Abuse Testing Ingredients Market Overview 1.2 Why You Should Read This Report 1.3 Global Drug of Abuse Testing Market Segmentation 1.4 How This Report Delivers 1.5 Key Questions Answered by This Analytical Report Include: 1.6 Who is This Report for? 1.7 Methodology 1.7.1 Primary Research 1.7.2 Secondary Research 1.7.3 Market Evaluation& Forecasting Methodology 1.8 Frequently Asked Questions (FAQ) 1.9 Associated Visiongain Reports 1.10 About visiongain
2. Introduction to the Drug of Abuse Testing market 2.1 What is Drug of Abuse Testing? 2.2 What is Drug of Abuse Testing Used For? 2.3 What Does the Test Result Mean?
3. Global Drug of Abuse Testing Market 2017-2027 3.1 Global Drug of Abuse Testing Market Forecast 2017-2027 3.2 Porters Five Forces Analysis 3.3 Threat of New Entrants 3.4 Threat of Substitutes 3.5 Bargaining Power of Suppliers 3.6 Bargaining Power of Buyers 3.7 Competitive Rivalry 3.8 Global Drug of Abuse Testing Market Drivers and Restraints 2017 3.8.1 Drivers 3.8.2 Increasing production and trafficking of illegal drugs 3.8.3 Increase in drug related deaths and accidents 3.8.4 Increasing demand for high safety and productivity of employees 3.8.5 Mandate drug testing policies 3.8.6 Restraints 3.8.7 Duping the drug of abuse test
4. Global Drug of Abuse Testing Market by Type, 2017-2027 4.1 Drug of Abuse Testing Market Shares by Type 4.1.1 Employment Testing Submarket Forecast 2017-2027 4.1.2 Random Testing Submarket Forecast 2017-2027 4.1.3 Reasonable Testing Submarket Forecast 2017-2027 4.1.4 Post-Accident Testing Submarket Forecast 2017-2027
5. Global Drug of Abuse Testing Market by Sample Type, 2017-2027 5.1 Drug of Abuse Testing Market Shares by Sample Type 5.1.1 Saliva Sample Type Submarket Forecast 2017-2027 5.1.2 Breath Sample Type Submarket Forecast 2017-2027 5.1.3 Urine Sample Type Submarket Forecast 2017-2027 5.1.4 Blood Sample Type Submarket Forecast 2017-2027 5.1.5 Hair Sample Type Submarket Forecast 2017-2027 5.1.6 Sweat Sample Type Submarket Forecast 2017-2027
6. Global Drug of Abuse Testing Market by Application, 2017-2027 6.1 Drug of Abuse Testing Market Shares by Application 6.1.1 Schools and Educational Institutes Submarket Forecast 2017-2027 6.1.2 Hospitals and Healthcare Units Submarket Forecast 2017-2027 6.1.3 Government and Private Departments Submarket Forecast 2017-2027 6.1.4 Other Submarket Forecast 2017-2027
7. Leading National Drug of Abuse Testing Markets Forecast 2017-2027 7.1 North America Drug of Abuse Testing Market Regional Analysis 7.2 Latin America Drug of Abuse Testing Market Regional Analysis 7.3 Europe Drug of Abuse Testing Market Regional Analysis 7.4 APEJ Drug of Abuse Testing Market Regional Analysis 7.5 Japan Drug of Abuse Testing Market Regional Analysis 7.6 MEA Drug of Abuse Testing Market Regional Analysis
8. Leading Players in Global Drug of Abuse Testing Market 2017-2027 8.1 Abbott Industries 8.1.1 Company Overview 8.1.2 Company Snapshot 8.1.3 Product Portfolio 8.1.4 Business performance 8.1.5 Key Developments 8.2 Danaher Corporation 8.2.1 Company overview 8.2.2 Company Snapshot 8.2.3 Product portfolio 8.2.4 Business performance 8.2.5 Key Developments 8.3 F. Hoffmann-La Roche AG (Roche Diagnostics) 8.3.1 Company overview 8.3.2 Company snapshot 8.3.3 Operating business segments 8.3.4 Product portfolio 8.3.5 Business Performance 8.3.6 Key Developments 8.4 Bio-Rad Laboratories, Inc. 8.4.1 Company overview 8.4.2 Company snapshot 8.4.3 Operating business segments 8.4.4 Product portfolio 8.4.5 Business Performance 8.4.6 Key Developments 8.5 Express Diagnostics International Inc. 8.5.1 Company overview 8.5.2 Operating business segments 8.5.3 Business Performance 8.5.4 Key Developments 8.6 Quest Diagnostics Incorporated 8.6.1 Company overview 8.6.2 Company snapshot 8.6.3 Operating business segments 8.6.4 Product portfolio 8.6.5 Business Performance 8.6.6 Key Developments 8.7 Siemens Aktiengesellschaft 8.7.1 Company overview 8.7.2 Company snapshot 8.7.3 Operating segments 8.7.4 Product portfolio 8.7.5 Business Performance 8.7.6 Key Developments 8.8 Thermo Fisher Scientific Inc. 8.8.1 Company overview 8.8.2 Company snapshot 8.8.3 Operating business segments 8.8.4 Product portfolio 8.8.5 Business Performance 8.8.6 Key Developments 8.9 Agilent Technologies Inc. 8.9.1 Company overview 8.9.2 Company snapshot 8.9.3 Operating business segments 8.9.4 Product portfolio 8.9.5 Business Performance 8.9.6 Key Developments 8.10 BioMerieux, Inc. 8.10.1 Company Overview: 8.10.2 Company snapshot 8.10.3 Business Performance 8.10.4 Key Developments
9. Conclusion Appendices Visiongain Associated Report Visiongain Report Sales Order Form About Visiongain Visiongain report evaluation form
List of Tables Table 3.1 Global Drug of Abuse Testing Market Forecast ($M, AGR%, CAGR%) 2016-2027 Table 4.1 Global Drug of Abuse Testing Market Forecast by Type: ($M, AGR%, CAGR%) 2016-2027 Table 4.2 Employment Testing Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027 Table 4.3 Random Testing Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027 Table 4.4 Reasonable Testing Submarket Forecast by Region ($M, AGR%, CAGR%) 2016-2027 Table 4.5 Post-Accident Testing Submarket Forecast by Region ($M, AGR%, CAGR%) 2016-2027 Table 5.1 Global Drug of Abuse Testing Market Forecast by Sample Type ($M, AGR%, CAGR%) 2016-2027 Table 5.2 Saliva Testing Submarket Forecast by Region ($M, AGR%, CAGR%) 2016-2027 Table 5.3 Breath Testing Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027 Table 5.4 Urine Testing Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027 Table 5.5 Blood Testing Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027 Table 5.6 Hair Testing Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027 Table 5.7 Sweat Testing Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027 Table 6.1 Global Drug of Abuse Testing Market Forecast by Application: ($M, AGR%, CAGR%) 2016-2027 Table 6.2 Schools and Educational Institutes Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027 Table 6.3 Hospitals and Healthcare Units Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027 Table 6.4 Government and Private Departments Submarket Forecast by Region: ($M, AGR%) 2016-2027 Table 6.5 Other Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027 Table 7.1 Global Drug of Abuse Testing Market Forecast by Region: ($M, AGR%, CAGR%) 2016-2027 Table 7.2 North America Drug of Abuse Testing Market Forecast by Type: ($M, AGR%, CAGR%) 2016-2027 Table 7.3 North America Drug of Abuse Testing Market Forecast by Sample Type: ($M, AGR%, CAGR%) 2016-2027 Table 7.4 North America Drug of Abuse Testing Market Forecast by Application: ($M, AGR%, CAGR%) 2016-2027 Table 7.5 North America Drug of Abuse Testing Market Forecast by Country: ($M, AGR%, CAGR%) 2016-2027 Table 7.6 Latin America Drug of Abuse Testing Market Forecast by Type: ($M, AGR%, CAGR%) 2016-2027 Table 7.7 Latin America Drug of Abuse Testing Market Forecast by Sample Type: ($M, AGR%, CAGR%) 2016-2027 Table 7.8 Latin America Drug of Abuse Testing Market Forecast by Application: ($M, AGR%, CAGR%) 2016-2027 Table 7.9 Latin America Drug of Abuse Testing Market Forecast by Country: ($M, AGR%, CAGR%) 2016-2027 Table 7.10 Europe Drug of Abuse Testing Market Forecast by Type: ($M, AGR%, CAGR%) 2016-2027 Table 7.11 Europe Drug of Abuse Testing Market Forecast by Sample Type: ($M, AGR%, CAGR%) 2016-2027 Table 7.12 Europe Drug of Abuse Testing Market Forecast by Application: ($M, AGR%, CAGR%) 2016-2027 Table 7.13 Europe Drug of Abuse Testing Market Forecast by Country: ($M, AGR%, CAGR%) 2016-2027 Table 7.14 APEJ Drug of Abuse Testing Market Forecast by Type: ($M, AGR%, CAGR%) 2016-2027 Table 7.15 APEJ Drug of Abuse Testing Market Forecast by Sample Type: ($M, AGR%, CAGR%) 2016-2027 Table 7.16 APEJ Drug of Abuse Testing Market Forecast by Application: ($M, AGR%, CAGR%) 2016-2027 Table 7.17 APEJ Drug of Abuse Testing Market Forecast by Country: ($M, AGR%, CAGR%) 2016-2027 Table 7.18 Japan Drug of Abuse Testing Market Forecast by Type ($M, AGR%, CAGR%) 2016-2027 Table 7.19 Japan Drug of Abuse Testing Market Forecast by Sample Type ($M, AGR%, CAGR%) 2016-2027 Table 7.20 Japan Drug of Abuse Testing Market Forecast by Application: ($M, AGR%, CAGR%) 2016-2027 Table 7.21 MEA Drug of Abuse Testing Market Forecast by Type: ($M, AGR%, CAGR%) 2016-2027 Table 7.22 MEA Drug of Abuse Testing Market Forecast by Sample Type: ($M, AGR%, CAGR%) 2016-2027 Table 7.23 MEA Drug of Abuse Testing Market Forecast by Application: ($M, AGR%, CAGR%) 2016-2027 Table 7.24 MEA Drug of Abuse Testing Market Forecast by Country: ($M, AGR%, CAGR%) 2016-2027 Table 8.1. Company Snapshot: Abbott Laboratories Table 8.2. Business Segments: Abbott Laboratories Table 8.3. Product Portfolio: Abbott Laboratories Table 8.4. Key Developments: Abbott Laboratories Table 8.5. Company Snapshot: Danaher Corporation Table 8.6. Business Segments: Danaher Corporation Table 8.7. Product Portfolio: Danaher Corporation Table 8.8. Key Developments: Danaher Corporation Table 8.9. Company Snapshot: F. Hoffmann-La Roche Ag Table 8.10. Business Segments: F. Hoffmann-La Roche Ag Table 8.11. Product Portfolio: F. Hoffmann-La Roche Ag Table 8.12. Key Developments: F. Hoffmann-La Roche Ag Table 8.13. Company Snapshots: Bio-Rad Laboratories, Inc. Table 8.14. Business Segments: Bio-Rad Laboratories, Inc. Table 8.15. Product Portfolio: Bio-Rad Laboratories, Inc. Table 8.16. Key Developments: Bio-Rad Laboratories, Inc. Table 8.17. Company Snapshot: Express Diagnostics International Inc. Table 8.18. Business Segments: Express Diagnostics International Inc. Table 8.19. Key Developments: Express Diagnostics International Inc. Table 8.20. Company Snapshot: Quest Diagnostics Incorporated Table 8.21. Business Segments: Quest Diagnostics Incorporated Table 8.22. Product Portfolio: Quest Diagnostics Incorporated Table 8.23. Key Developments: Quest Diagnostics Incorporated Table 8.24. Company Snapshots: Siemens Ag Table 8.25. Business Segments: Siemens Ag Table 8.26. Product Portfolio: Siemens Ag Table 8.27. Key Developments: Siemens Ag Table 8.28. Key Developments: Thermo Fisher Scientific Inc. Table 8.29. Operating Segments: Thermo Fisher Scientific Inc. Table 8.30. Product Portfolio: Thermo Fisher Scientific Inc. Table 8.31. Key Developments: Thermo Fisher Scientific Inc. Table 8.32. Company Snapshot: Agilent Technologies Inc. Table 8.33. Business Segments: Agilent Technologies Inc. Table 8.34. Product Portfolio: Agilent Technologies Inc. Table 8.35. Key Developments: Agilent Technologies Inc. Table 8.36. Company Snapshot: Biomerieux, Inc.
List of Figure Figure 1.2 Global Drug of Abuse Testing Market Segmentation Figure 4.1 Global Drug of Abuse Testing Market by Type: Growth Rate Forecast (AGR %) 2017-2027 Figure 4.2 Global Drug of Abuse Testing Market Shares by Type: (% Share), 2016 Figure 4.3 Global Drug of Abuse Testing Market Shares by Type: (% Share), 2022 Figure 4.4 Global Drug of Abuse Testing Market Shares by Type: (% Share), 2027 Figure 4.5 Employment Testing Submarket Forecast ($M, AGR%), 2017-2027 Figure 4.6 Random Testing Submarket Forecast ($M, AGR%), 2017-2027 Figure 4.7 Reasonable Testing Submarket Forecast ($M, AGR%), 2017-2027 Figure 4.8 Post-Accident Testing Submarket Forecast ($M, AGR%), 2017-2027 Figure 5.1 Drug of Abuse Testing Market by Sample Type: Growth Rate Forecast: (AGR %), 2017-2027 Figure 5.2 Global Drug of Abuse Testing Market Shares by Sample Type: (% Share), 2016 Figure 5.3 Global Drug of Abuse Testing Market Shares by Sample Type: (% Share), 2022 Figure 5.4 Global Drug of Abuse Testing Market Shares by Sample Type: (% Share), 2027 Figure 5.5 Saliva Testing Submarket Forecast ($M, AGR%), 2017-2027 Figure 5.6 Breath Testing Submarket Forecast ($M, AGR%), 2017-2027 Figure 5.7 Urine Testing Submarket Forecast ($M, AGR%), 2017-2027 Figure 5.8 Blood Testing Submarket Forecast ($M, AGR%), 2017-2027 Figure 5.9 Hair Testing Submarket Forecast ($M, AGR%), 2017-2027 Figure 5.10 Sweat Testing Submarket Forecast ($M, AGR%), 2017-2027 Figure 6.1 Drug of Abuse Testing Market by Application: Growth Rate Forecast (AGR %), 2017-2027 Figure 6.2 Global Drug of Abuse Testing Market Shares by Application: (% Share), 2016 Figure 6.3 Global Drug of Abuse Testing Market Shares by Application: (% Share), 2022 Figure 6.4 Global Drug of Abuse Testing Market Shares by Application: (% Share), 2027 Figure 6.5 Schools and Educational Institutes Submarket Forecast ($M, AGR%), 2017-2027 Figure 6.6 Hospitals and Healthcare Units Submarket Forecast ($M, AGR%), 2017-2027 Figure 6.7 Government and Private Departments Submarket Forecast ($M, AGR%), 2017-2027 Figure 6.8 Other Submarket Forecast ($M, AGR%), 2017-2027 Figure 7.1 Drug of Abuse Testing Market by Region: Growth Rate Forecast (AGR %), 2017-2027 Figure 7.2 North America Drug of Abuse Testing Market Shares by Country: (% Share), 2016 Figure 7.3 North America Drug of Abuse Testing Market Shares by Country: (% Share), 2022 Figure 7.4 North America Drug of Abuse Testing Market Shares by Country: (%), 2027 Figure 7.5 Latin America Drug of Abuse Testing Market Shares by Country: (% Share), 2016 Figure 7.6 Latin America Drug of Abuse Testing Market Shares by Country: (% Share), 2022 Figure 7.7 Latin America Drug of Abuse Testing Market Shares by Country: (% Share), 2027 Figure 7.8 Europe Drug of Abuse Testing Market Shares by Country: (% Share), 2016 Figure 7.9 Europe Drug of Abuse Testing Market Shares by Country: (% Share), 2022 Figure 7.10 Europe Drug of Abuse Testing Market Shares by Country: (% Share), 2027 Figure 7.11 APEJ Drug of Abuse Testing Market Shares by Country: (% Share), 2016 Figure 7.12 APEJ Drug of Abuse Testing Market Shares by Country: (% Share), 2022 Figure 7.13 APEJ Drug of Abuse Testing Market Shares by Country: (% Share), 2027 Figure 7.14 MEA Drug of Abuse Testing Market Shares by Country: (% Share), 2016 Figure 7.15 MEA Drug of Abuse Testing Market Shares by Country: (% Share), 2022 Figure 7.16 MEA Drug of Abuse Testing Market Shares by Country: (% Share), 2027 Figure 8.1 Abbott: Net Sales, 2014–2016 ($Million) Figure 8.2 Abbott: Revenue by Segment, 2016 (%) Figure 8.3 Abbott: Revenue by Geography, 2016 (%) Figure 8.4 Danaher Corporation: Net Sales, 2014-2016 ($Million) Figure 8.5 Danaher Corporation: Revenue by Segment, 2016 (%) Figure 8.6 Danaher Corporation: Revenue by Geography, 2016 (%) Figure 8.7 F. Hoffmann-La Roche Ag: Net Sales, 2014–2016 ($Million) Figure 8.8 F. Hoffmann-La Roche Ag: Revenue by Segment (%) Figure 8.9 F. Hoffmann-La Roche Ag: Revenue by Geography (%) Figure 8.10 Bio-Rad Laboratories, Inc.: Net Sales, 2014–2016 ($Million) Figure 8.11 Bio-Rad Laboratories, Inc.: Revenue Share by Segment, 2016 (%) Figure 8.12 Bio-Rad Laboratories, Inc.: Revenue Share by Segment, 2016 (%) Figure 8.13 Quest Diagnostics Incorporated: Net Sales, 2014-2016 ($ Million) Figure 8.14 Quest Diagnostics Incorporated: Revenue Share by Segment, 2016 (%) Figure 8.15 Siemens Ag: Net Sales, 2014–2016 ($Million) Figure 8.16 Siemens Ag: Revenue Share by Segment, 2016 (%) Figure 8.16 Siemens Ag: Revenue Share by Geography, 2016 (%) Figure 8.18 Thermo Fisher: Net Sales, 2014–2016 ($Million) Figure 8.19 Thermo Fisher: Revenue Share by Segment, 2016 (%) Figure 8.20 Thermo Fisher: Revenue Share by Geography, 2016 (%) Figure 8.21 Agilent Technologies Inc.: Net Sales, 2014–2016 ($Million) Figure 8.22 Agilent Technologies Inc.: Revenue by Segment, 2016 (%) Figure 8.23 Agilent Technologies Inc.: Revenue by Geography, 2016 (%) Figure 8.24 Biomeriux: Revenue by Geography (%) Figure 9.1 Global Drug of Abuse Testing Market Shares by Type Forecast: (% Share), 2016 Figure 9.2 Global Drug of Abuse Testing Market Shares by Sample Type: (% Share), 2016 Figure 9.3 Leading Drug of Abuse Testing Application Submarkets Shares by Application: (% Share), 2016 Figure 9.4 Leading Drug of Abuse Testing Regional Submarkets Shares by Country: (% Share), 2016
Abbott Agilent Technologies, Inc. Alere Ariosa Diagnostics, Inc. BioMerieux, Inc. Bio-Rad Laboratories Biotest AG Cepheid Chugai Danahere Express Diagnostics Global, Ltd. (EDG) Express Diagnostics International, Inc. GeneWEAVE, Inc. International Association of Athletics Federations (IAAF) Karolinska Institute Quest Diagnostics Incorporated Roche Siemens Society of Hair Testing Thermo Fisher Scientific, Inc. U.S. Anti-Doping Agency (USADA) U.S. Department of Education U.S. Department of Transportation World Anti-Doping Agency (WADA)
Download sample pages
Complete the form below to download your free sample pages for Global Drug of Abuse Testing Market Report 2017-2027
Download sample pages
Complete the form below to download your free sample pages for Global Drug of Abuse Testing Market Report 2017-2027
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
